[Retracted] CuO‐TiO2‐Chitosan‐Berbamine Nanocomposites Induce Apoptosis through the Mitochondrial Pathway with the Expression of P53, BAX, and BCL‐2 in the Human K562 Cancer Cell Line
Open Access
- 17 September 2022
- journal article
- retracted article
- Published by Wiley in Bioinorganic Chemistry and Applications
- Vol. 2022 (1) , 9602725
Abstract
In this study, cells from human Chronic Myelogenous Leukemia (K562) were cultivated with CuO‐TiO2‐Chitosan‐Berbamine nanocomposites. We examined nanocomposites using XRD, DLS, FESEM, TEM, PL, EDAX, and FTIR spectroscopy, as well as MTT for cytotoxicity, and AO/EtBr for apoptotic morphology assessment. The rate of apoptosis and cell cycle arrests was determined using flow cytometry. Flow cytometry was also employed to identify pro‐ and antiapoptotic proteins such as Bcl2, Bad, Bax, P53, and Cyt C. The FTIR spectrum revealed that the CuO‐TiO2‐Chitosan‐Berbamine nanocomposites were electrostatically interlocked. The nanocomposites’ XRD signals revealed a hexagonal shape. In the DLS spectrum, nanocomposites were found to have a hydrodynamic diameter. As a result of their cytotoxic action, nanocomposites displayed concentration‐dependent cytotoxicity. The nanocomposites, like Doxorubicin, caused cell cycle phase arrest in K562 cells. After treatment with IC50 concentrations of CuO‐TiO2‐Chitosan‐Berbamine nanocomposites and Doxorubicin, a substantial percentage of cells were in G2/M stage arrest. Caspase‐3, ‐7, ‐8, ‐9, Bax, Bad, Cyt C, and P53 expression were considerably enhanced in K562 cells, whereas Bcl2 expression was decreased, indicating that these cells may have therapeutic potential against human blood cancer/leukemia‐derived disorders. As a result, the nanocomposites demonstrated outstanding anticancer potential against leukemic cells. CuO‐TiO2‐Chitosan‐Berbamine, according to our findings.Keywords
Funding Information
- Jouf University (DSR2022-RG-0155)
This publication has 57 references indexed in Scilit:
- Management of imatinib-resistant patients with chronic myeloid leukemiaTherapeutic Advances in Hematology, 2012
- CuO/TiO2 nanocrystals grown on graphene as visible-light responsive photocatalytic hybrid materialsBulletin of Materials Science, 2012
- Role of Bcl-2 family proteins and caspases in the regulation of apoptosisMolecular and Cellular Biochemistry, 2011
- Suppression of human lung cancer cell growth and migration by berbamineCytotechnology, 2009
- Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of actionMolecular Cancer, 2009
- Berbamine derivatives: A novel class of compounds for anti-leukemia activityEuropean Journal of Medicinal Chemistry, 2009
- Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude miceJournal of Asian Natural Products Research, 2009
- Caspases in apoptosis and beyondOncogene, 2008
- Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembrane potential and caspase activationJournal of Zhejiang University-SCIENCE B, 2007
- Risk Factors for Acute Leukemia in Children: A ReviewEnvironmental Health Perspectives, 2007